Tech Company Financing Transactions
SHINE Medical Technologies Funding Round
SHINE Medical Technologies closed a $125 million investment round on 10/10/2014. Backers included Deerfield Capital.
Transaction Overview
Company Name
Announced On
10/10/2014
Transaction Type
Debt
Amount
$125,000,000
Round
Undisclosed
Investors
Deerfield Capital (Steven Hochberg)
Proceeds Purpose
SHINE plans to build a new manufacturing plant in Wisconsin to produce more than a quarter of world supply of the most commonly-used isotope in nuclear medicine, molybdenum-99 (moly-99).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
101 E. Milwaukee St. 600
Janesville, WI 53545
USA
Janesville, WI 53545
USA
Phone
Website
Email Address
Overview
SHINE Medical Technologies is dedicated to being the world leader in safe, clean, affordable production of medical tracers and cancer treatment elements.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Piefer
Chief Financial Officer
Chris Lee
Chief Operating Officer
Steve Miltenberger
Chief Technical Officer
Eric Abel
President
Todd Asmuth
VP - Bus. Development
Katrina Pitas
VP - Engineering
Tracy Radel
VP - General Counsel
Nathan Schleifer
VP - Human Resources
Eric Schutt
VP - Regulatory Affairs
James Costedio
VP - Sales
Harrie Buurlage
Browse more venture capital transactions:
Prev: 10/10/2014: Evtron venture capital transaction
Next: 10/10/2014: TRIA Beauty venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs